169 related articles for article (PubMed ID: 2488698)
1. Quantification and topographical description of Ki-67 antibody labelling during the cell cycle of normal fibroblastic (MRC-5) and mammary tumour cell lines (MCF-7).
Guillaud P; du Manoir S; Seigneurin D
Anal Cell Pathol; 1989 Feb; 1(1):25-39. PubMed ID: 2488698
[TBL] [Abstract][Full Text] [Related]
2. Interactive computer-assisted analysis of chromosome 1 colocalization with nucleoli.
Léger I; Guillaud M; Krief B; Brugal G
Cytometry; 1994 Aug; 16(4):313-23. PubMed ID: 7988293
[TBL] [Abstract][Full Text] [Related]
3. Ki-67 labeling in postmitotic cells defines different Ki-67 pathways within the 2c compartment.
du Manoir S; Guillaud P; Camus E; Seigneurin D; Brugal G
Cytometry; 1991; 12(5):455-63. PubMed ID: 1935459
[TBL] [Abstract][Full Text] [Related]
4. Comparative flow cytometric analysis of Ki-67 and proliferating cell nuclear antigen (PCNA) in solid neoplasms.
Steck K; el-Naggar AK
Cytometry; 1994 Nov; 17(3):258-65. PubMed ID: 7851161
[TBL] [Abstract][Full Text] [Related]
5. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen.
Yu CC; Dublin EA; Camplejohn RS; Levison DA
Anal Cell Pathol; 1995 Jul; 9(1):45-52. PubMed ID: 7577754
[TBL] [Abstract][Full Text] [Related]
6. Expression of nucleolar protein p120 in human lung cancer: difference in histological types as a marker for proliferation.
Uchiyama B; Saijo Y; Kumano N; Abe T; Fujimura S; Ohkuda K; Handa M; Satoh K; Nukiwa T
Clin Cancer Res; 1997 Oct; 3(10):1873-7. PubMed ID: 9815576
[TBL] [Abstract][Full Text] [Related]
7. Nuclear distribution of the Ki-67 antigen during the cell cycle: comparison with growth fraction in human breast cancer cells.
van Dierendonck JH; Keijzer R; van de Velde CJ; Cornelisse CJ
Cancer Res; 1989 Jun; 49(11):2999-3006. PubMed ID: 2720660
[TBL] [Abstract][Full Text] [Related]
8. A technique for automatic/interactive assessment of the proliferating fraction of neoplastic cells in solid tumors. A methodological study on the Ki-67 immunoreactive cells in human mammary carcinomas, including a comparison with the results of conventional S-phase fraction assessments by means of DNA cytometry.
Parrado C; Falkmer UG; Höög A; Falkmer S; Ahrens O; Rius F; Grimelius L
Gen Diagn Pathol; 1996 Mar; 141(3-4):215-27. PubMed ID: 8705786
[TBL] [Abstract][Full Text] [Related]
9. Immunocytochemistry and image cytometry of progesterone receptors in breast carcinoma imprints. Expression of tissular and cellular heterogeneity: relations to biochemical assay, clinical and histological parameters and DNA analysis.
Seigneurin D; Cohen O; Louis J
Anal Cell Pathol; 1989 Apr; 1(2):97-104. PubMed ID: 2484853
[TBL] [Abstract][Full Text] [Related]
10. The immunohistochemical marker Ki-S2: cell cycle kinetics and tissue distribution of a novel proliferation-specific antigen.
Rudolph P; Knüchel R; Endl E; Heidebrecht HJ; Hofstäder F; Parwaresch R
Mod Pathol; 1998 May; 11(5):450-6. PubMed ID: 9619598
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of claspin as a proliferation marker in human cancer and normal tissues.
Tsimaratou K; Kletsas D; Kastrinakis NG; Tsantoulis PK; Evangelou K; Sideridou M; Liontos M; Poulias I; Venere M; Salmas M; Kittas C; Halazonetis TD; Gorgoulis VG
J Pathol; 2007 Feb; 211(3):331-9. PubMed ID: 17152083
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence image analysis of the MCF-7 cycle related changes in chromatin texture. Differences between AT- and GC-rich chromatin.
Santisteban MS; Brugal G
Anal Cell Pathol; 1995 Jul; 9(1):13-28. PubMed ID: 7577751
[TBL] [Abstract][Full Text] [Related]
13. [Ki-67 antigen, a cell cycle and tumor growth marker].
Seigneurin D; Guillaud P
Pathol Biol (Paris); 1991 Dec; 39(10):1020-8. PubMed ID: 1666669
[TBL] [Abstract][Full Text] [Related]
14. Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies.
Gerdes J
Semin Cancer Biol; 1990 Jun; 1(3):199-206. PubMed ID: 2103495
[TBL] [Abstract][Full Text] [Related]
15. Effect of staurosporine on MOLT-4 cell progression through G2 and on cytokinesis.
Traganos F; Gong J; Ardelt B; Darzynkiewicz Z
J Cell Physiol; 1994 Mar; 158(3):535-44. PubMed ID: 8126077
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of proliferating cells in acute leukemia with antibodies to proliferating cell nuclear antigen and Ki-67 monoclonal antibodies.
Inoue T; Yamane T; Park K; Im T; Tatsumi N; Okuda K
Arch Pathol Lab Med; 1993 Oct; 117(10):969-72. PubMed ID: 8105766
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric evaluation of Ki67 proliferative antigen in primary breast cancer.
Niezabitowski A; Lackowska B; Ryś J; Gruchała A; Szklarski W; Stelmach A; Wasilewska A; Kruczak A; Swiatkiewicz I
Pol J Pathol; 1995; 46(1):17-22. PubMed ID: 7780692
[TBL] [Abstract][Full Text] [Related]
18. Cell proliferation-associated nuclear antigen defined by antibody Ki-67: a new kind of cell cycle-maintaining proteins.
Duchrow M; Schlüter C; Key G; Kubbutat MH; Wohlenberg C; Flad HD; Gerdes J
Arch Immunol Ther Exp (Warsz); 1995; 43(2):117-21. PubMed ID: 8744726
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of AgNOR and Ki-67 antigen as cell kinetic parameters in oral dysplasias and carcinomas.
Zoeller J; Flentje M; Sinn P; Born IA
Anal Cell Pathol; 1994 Jul; 7(1):77-88. PubMed ID: 7981138
[TBL] [Abstract][Full Text] [Related]
20. [In situ determination of the Ki-67 growth fraction (Ki-67 GF) in human tumors (studies in breast cancer)].
Lellé RJ
Acta Histochem Suppl; 1990; 39():109-24. PubMed ID: 2080254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
